Search
for
Sort by
Research 751–780 of 1000+
- Highlights of This Issue
- Finasteride, To Take, or Not to Take
- Finasteride: not guilty after all?
- Finasteride en el año 2006
- Reply by the authors
- Finasteride en de preventie van prostaatcarcinoom
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- New Methods of Endocrine Management of Prostatic Cancer
- Chemopr�vention des Prostatakarzinoms
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Editorial Comment
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
- Chemoprävention des Prostatakarzinoms - Ein Plädoyer
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Editorial Comment
- ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story
- Ductal breast cancer in a male patient
- Reply
- Finasteride
- Finasteride chemoprevention might be cost-effective in high-risk populations
- 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34
- マストミス雌雄前立腺における5α-reductase inhibitor (Finasteride)の影響
- Basic Scientists Investigate Biochemical Basis of Ancient Chinese Medicines
- ダブルストロボレンジファインダの開発(特別講演)(画像センシングおよび一般)
- Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
- Pharmacology and Potential Use of Cyproterone Acetate